Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Veterinary Biologics Market Growth 2022-2028

  • LP 4894302
  • 126 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Veterinary Biologics will have significant change from previous year. According to our (LP Information) latest study, the global Veterinary Biologics market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Veterinary Biologics market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Veterinary Biologics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Veterinary Biologics market, reaching US$ million by the year 2028. As for the Europe Veterinary Biologics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Veterinary Biologics players cover Merck, Zoetis, Boehringer Ingelheim, and Ceva, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Biologics market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Vaccines

Monoclonal Antibodies

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Llivestock

Equine

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Merck

Zoetis

Boehringer Ingelheim

Ceva

CAHIC

HVRI

Ringpu Biology

Yebio

DHN

WINSUN

Elanco/Eli Lilly

Virbac

Jinyu Bio-Technology

ChengDu Tecbond

CAVAC

Kyoto Biken

FATRO

Vaksindo

Bio-Labs

Avimex Animal

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Veterinary Biologics Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Veterinary Biologics by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Veterinary Biologics by Country/Region, 2017, 2022 & 2028

2.2 Veterinary Biologics Segment by Type

2.2.1 Vaccines

2.2.2 Monoclonal Antibodies

2.3 Veterinary Biologics Sales by Type

2.3.1 Global Veterinary Biologics Sales Market Share by Type (2017-2022)

2.3.2 Global Veterinary Biologics Revenue and Market Share by Type (2017-2022)

2.3.3 Global Veterinary Biologics Sale Price by Type (2017-2022)

2.4 Veterinary Biologics Segment by Application

2.4.1 Llivestock

2.4.2 Equine

2.4.3 Other

2.5 Veterinary Biologics Sales by Application

2.5.1 Global Veterinary Biologics Sale Market Share by Application (2017-2022)

2.5.2 Global Veterinary Biologics Revenue and Market Share by Application (2017-2022)

2.5.3 Global Veterinary Biologics Sale Price by Application (2017-2022)

3 Global Veterinary Biologics by Company

3.1 Global Veterinary Biologics Breakdown Data by Company

3.1.1 Global Veterinary Biologics Annual Sales by Company (2020-2022)

3.1.2 Global Veterinary Biologics Sales Market Share by Company (2020-2022)

3.2 Global Veterinary Biologics Annual Revenue by Company (2020-2022)

3.2.1 Global Veterinary Biologics Revenue by Company (2020-2022)

3.2.2 Global Veterinary Biologics Revenue Market Share by Company (2020-2022)

3.3 Global Veterinary Biologics Sale Price by Company

3.4 Key Manufacturers Veterinary Biologics Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Veterinary Biologics Product Location Distribution

3.4.2 Players Veterinary Biologics Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Veterinary Biologics by Geographic Region

4.1 World Historic Veterinary Biologics Market Size by Geographic Region (2017-2022)

4.1.1 Global Veterinary Biologics Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Veterinary Biologics Annual Revenue by Geographic Region

4.2 World Historic Veterinary Biologics Market Size by Country/Region (2017-2022)

4.2.1 Global Veterinary Biologics Annual Sales by Country/Region (2017-2022)

4.2.2 Global Veterinary Biologics Annual Revenue by Country/Region

4.3 Americas Veterinary Biologics Sales Growth

4.4 APAC Veterinary Biologics Sales Growth

4.5 Europe Veterinary Biologics Sales Growth

4.6 Middle East & Africa Veterinary Biologics Sales Growth

5 Americas

5.1 Americas Veterinary Biologics Sales by Country

5.1.1 Americas Veterinary Biologics Sales by Country (2017-2022)

5.1.2 Americas Veterinary Biologics Revenue by Country (2017-2022)

5.2 Americas Veterinary Biologics Sales by Type

5.3 Americas Veterinary Biologics Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Veterinary Biologics Sales by Region

6.1.1 APAC Veterinary Biologics Sales by Region (2017-2022)

6.1.2 APAC Veterinary Biologics Revenue by Region (2017-2022)

6.2 APAC Veterinary Biologics Sales by Type

6.3 APAC Veterinary Biologics Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Veterinary Biologics by Country

7.1.1 Europe Veterinary Biologics Sales by Country (2017-2022)

7.1.2 Europe Veterinary Biologics Revenue by Country (2017-2022)

7.2 Europe Veterinary Biologics Sales by Type

7.3 Europe Veterinary Biologics Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Veterinary Biologics by Country

8.1.1 Middle East & Africa Veterinary Biologics Sales by Country (2017-2022)

8.1.2 Middle East & Africa Veterinary Biologics Revenue by Country (2017-2022)

8.2 Middle East & Africa Veterinary Biologics Sales by Type

8.3 Middle East & Africa Veterinary Biologics Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Veterinary Biologics

10.3 Manufacturing Process Analysis of Veterinary Biologics

10.4 Industry Chain Structure of Veterinary Biologics

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Veterinary Biologics Distributors

11.3 Veterinary Biologics Customer

12 World Forecast Review for Veterinary Biologics by Geographic Region

12.1 Global Veterinary Biologics Market Size Forecast by Region

12.1.1 Global Veterinary Biologics Forecast by Region (2023-2028)

12.1.2 Global Veterinary Biologics Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Veterinary Biologics Forecast by Type

12.7 Global Veterinary Biologics Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck Veterinary Biologics Product Offered

13.1.3 Merck Veterinary Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 Zoetis

13.2.1 Zoetis Company Information

13.2.2 Zoetis Veterinary Biologics Product Offered

13.2.3 Zoetis Veterinary Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Zoetis Main Business Overview

13.2.5 Zoetis Latest Developments

13.3 Boehringer Ingelheim

13.3.1 Boehringer Ingelheim Company Information

13.3.2 Boehringer Ingelheim Veterinary Biologics Product Offered

13.3.3 Boehringer Ingelheim Veterinary Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Boehringer Ingelheim Main Business Overview

13.3.5 Boehringer Ingelheim Latest Developments

13.4 Ceva

13.4.1 Ceva Company Information

13.4.2 Ceva Veterinary Biologics Product Offered

13.4.3 Ceva Veterinary Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Ceva Main Business Overview

13.4.5 Ceva Latest Developments

13.5 CAHIC

13.5.1 CAHIC Company Information

13.5.2 CAHIC Veterinary Biologics Product Offered

13.5.3 CAHIC Veterinary Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 CAHIC Main Business Overview

13.5.5 CAHIC Latest Developments

13.6 HVRI

13.6.1 HVRI Company Information

13.6.2 HVRI Veterinary Biologics Product Offered

13.6.3 HVRI Veterinary Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 HVRI Main Business Overview

13.6.5 HVRI Latest Developments

13.7 Ringpu Biology

13.7.1 Ringpu Biology Company Information

13.7.2 Ringpu Biology Veterinary Biologics Product Offered

13.7.3 Ringpu Biology Veterinary Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Ringpu Biology Main Business Overview

13.7.5 Ringpu Biology Latest Developments

13.8 Yebio

13.8.1 Yebio Company Information

13.8.2 Yebio Veterinary Biologics Product Offered

13.8.3 Yebio Veterinary Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Yebio Main Business Overview

13.8.5 Yebio Latest Developments

13.9 DHN

13.9.1 DHN Company Information

13.9.2 DHN Veterinary Biologics Product Offered

13.9.3 DHN Veterinary Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 DHN Main Business Overview

13.9.5 DHN Latest Developments

13.10 WINSUN

13.10.1 WINSUN Company Information

13.10.2 WINSUN Veterinary Biologics Product Offered

13.10.3 WINSUN Veterinary Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 WINSUN Main Business Overview

13.10.5 WINSUN Latest Developments

13.11 Elanco/Eli Lilly

13.11.1 Elanco/Eli Lilly Company Information

13.11.2 Elanco/Eli Lilly Veterinary Biologics Product Offered

13.11.3 Elanco/Eli Lilly Veterinary Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Elanco/Eli Lilly Main Business Overview

13.11.5 Elanco/Eli Lilly Latest Developments

13.12 Virbac

13.12.1 Virbac Company Information

13.12.2 Virbac Veterinary Biologics Product Offered

13.12.3 Virbac Veterinary Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Virbac Main Business Overview

13.12.5 Virbac Latest Developments

13.13 Jinyu Bio-Technology

13.13.1 Jinyu Bio-Technology Company Information

13.13.2 Jinyu Bio-Technology Veterinary Biologics Product Offered

13.13.3 Jinyu Bio-Technology Veterinary Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Jinyu Bio-Technology Main Business Overview

13.13.5 Jinyu Bio-Technology Latest Developments

13.14 ChengDu Tecbond

13.14.1 ChengDu Tecbond Company Information

13.14.2 ChengDu Tecbond Veterinary Biologics Product Offered

13.14.3 ChengDu Tecbond Veterinary Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 ChengDu Tecbond Main Business Overview

13.14.5 ChengDu Tecbond Latest Developments

13.15 CAVAC

13.15.1 CAVAC Company Information

13.15.2 CAVAC Veterinary Biologics Product Offered

13.15.3 CAVAC Veterinary Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 CAVAC Main Business Overview

13.15.5 CAVAC Latest Developments

13.16 Kyoto Biken

13.16.1 Kyoto Biken Company Information

13.16.2 Kyoto Biken Veterinary Biologics Product Offered

13.16.3 Kyoto Biken Veterinary Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Kyoto Biken Main Business Overview

13.16.5 Kyoto Biken Latest Developments

13.17 FATRO

13.17.1 FATRO Company Information

13.17.2 FATRO Veterinary Biologics Product Offered

13.17.3 FATRO Veterinary Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 FATRO Main Business Overview

13.17.5 FATRO Latest Developments

13.18 Vaksindo

13.18.1 Vaksindo Company Information

13.18.2 Vaksindo Veterinary Biologics Product Offered

13.18.3 Vaksindo Veterinary Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Vaksindo Main Business Overview

13.18.5 Vaksindo Latest Developments

13.19 Bio-Labs

13.19.1 Bio-Labs Company Information

13.19.2 Bio-Labs Veterinary Biologics Product Offered

13.19.3 Bio-Labs Veterinary Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Bio-Labs Main Business Overview

13.19.5 Bio-Labs Latest Developments

13.20 Avimex Animal

13.20.1 Avimex Animal Company Information

13.20.2 Avimex Animal Veterinary Biologics Product Offered

13.20.3 Avimex Animal Veterinary Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Avimex Animal Main Business Overview

13.20.5 Avimex Animal Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Veterinary Biologics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Veterinary Biologics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Vaccines

Table 4. Major Players of Monoclonal Antibodies

Table 5. Global Veterinary Biologics Sales by Type (2017-2022) & (K Units)

Table 6. Global Veterinary Biologics Sales Market Share by Type (2017-2022)

Table 7. Global Veterinary Biologics Revenue by Type (2017-2022) & ($ million)

Table 8. Global Veterinary Biologics Revenue Market Share by Type (2017-2022)

Table 9. Global Veterinary Biologics Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Veterinary Biologics Sales by Application (2017-2022) & (K Units)

Table 11. Global Veterinary Biologics Sales Market Share by Application (2017-2022)

Table 12. Global Veterinary Biologics Revenue by Application (2017-2022)

Table 13. Global Veterinary Biologics Revenue Market Share by Application (2017-2022)

Table 14. Global Veterinary Biologics Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Veterinary Biologics Sales by Company (2020-2022) & (K Units)

Table 16. Global Veterinary Biologics Sales Market Share by Company (2020-2022)

Table 17. Global Veterinary Biologics Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Veterinary Biologics Revenue Market Share by Company (2020-2022)

Table 19. Global Veterinary Biologics Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Veterinary Biologics Producing Area Distribution and Sales Area

Table 21. Players Veterinary Biologics Products Offered

Table 22. Veterinary Biologics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Veterinary Biologics Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Veterinary Biologics Sales Market Share Geographic Region (2017-2022)

Table 27. Global Veterinary Biologics Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Veterinary Biologics Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Veterinary Biologics Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Veterinary Biologics Sales Market Share by Country/Region (2017-2022)

Table 31. Global Veterinary Biologics Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Veterinary Biologics Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Veterinary Biologics Sales by Country (2017-2022) & (K Units)

Table 34. Americas Veterinary Biologics Sales Market Share by Country (2017-2022)

Table 35. Americas Veterinary Biologics Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Veterinary Biologics Revenue Market Share by Country (2017-2022)

Table 37. Americas Veterinary Biologics Sales by Type (2017-2022) & (K Units)

Table 38. Americas Veterinary Biologics Sales Market Share by Type (2017-2022)

Table 39. Americas Veterinary Biologics Sales by Application (2017-2022) & (K Units)

Table 40. Americas Veterinary Biologics Sales Market Share by Application (2017-2022)

Table 41. APAC Veterinary Biologics Sales by Region (2017-2022) & (K Units)

Table 42. APAC Veterinary Biologics Sales Market Share by Region (2017-2022)

Table 43. APAC Veterinary Biologics Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Veterinary Biologics Revenue Market Share by Region (2017-2022)

Table 45. APAC Veterinary Biologics Sales by Type (2017-2022) & (K Units)

Table 46. APAC Veterinary Biologics Sales Market Share by Type (2017-2022)

Table 47. APAC Veterinary Biologics Sales by Application (2017-2022) & (K Units)

Table 48. APAC Veterinary Biologics Sales Market Share by Application (2017-2022)

Table 49. Europe Veterinary Biologics Sales by Country (2017-2022) & (K Units)

Table 50. Europe Veterinary Biologics Sales Market Share by Country (2017-2022)

Table 51. Europe Veterinary Biologics Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Veterinary Biologics Revenue Market Share by Country (2017-2022)

Table 53. Europe Veterinary Biologics Sales by Type (2017-2022) & (K Units)

Table 54. Europe Veterinary Biologics Sales Market Share by Type (2017-2022)

Table 55. Europe Veterinary Biologics Sales by Application (2017-2022) & (K Units)

Table 56. Europe Veterinary Biologics Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Veterinary Biologics Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Veterinary Biologics Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Veterinary Biologics Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Veterinary Biologics Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Veterinary Biologics Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Veterinary Biologics Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Veterinary Biologics Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Veterinary Biologics Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Veterinary Biologics

Table 66. Key Market Challenges & Risks of Veterinary Biologics

Table 67. Key Industry Trends of Veterinary Biologics

Table 68. Veterinary Biologics Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Veterinary Biologics Distributors List

Table 71. Veterinary Biologics Customer List

Table 72. Global Veterinary Biologics Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Veterinary Biologics Sales Market Forecast by Region

Table 74. Global Veterinary Biologics Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Veterinary Biologics Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Veterinary Biologics Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Veterinary Biologics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Veterinary Biologics Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Veterinary Biologics Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Veterinary Biologics Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Veterinary Biologics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Veterinary Biologics Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Veterinary Biologics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Veterinary Biologics Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Veterinary Biologics Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Veterinary Biologics Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Veterinary Biologics Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Veterinary Biologics Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Veterinary Biologics Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Veterinary Biologics Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Veterinary Biologics Revenue Market Share Forecast by Application (2023-2028)

Table 92. Merck Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 93. Merck Veterinary Biologics Product Offered

Table 94. Merck Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Merck Main Business

Table 96. Merck Latest Developments

Table 97. Zoetis Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 98. Zoetis Veterinary Biologics Product Offered

Table 99. Zoetis Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Zoetis Main Business

Table 101. Zoetis Latest Developments

Table 102. Boehringer Ingelheim Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 103. Boehringer Ingelheim Veterinary Biologics Product Offered

Table 104. Boehringer Ingelheim Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Boehringer Ingelheim Main Business

Table 106. Boehringer Ingelheim Latest Developments

Table 107. Ceva Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 108. Ceva Veterinary Biologics Product Offered

Table 109. Ceva Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Ceva Main Business

Table 111. Ceva Latest Developments

Table 112. CAHIC Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 113. CAHIC Veterinary Biologics Product Offered

Table 114. CAHIC Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. CAHIC Main Business

Table 116. CAHIC Latest Developments

Table 117. HVRI Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 118. HVRI Veterinary Biologics Product Offered

Table 119. HVRI Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. HVRI Main Business

Table 121. HVRI Latest Developments

Table 122. Ringpu Biology Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 123. Ringpu Biology Veterinary Biologics Product Offered

Table 124. Ringpu Biology Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Ringpu Biology Main Business

Table 126. Ringpu Biology Latest Developments

Table 127. Yebio Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 128. Yebio Veterinary Biologics Product Offered

Table 129. Yebio Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Yebio Main Business

Table 131. Yebio Latest Developments

Table 132. DHN Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 133. DHN Veterinary Biologics Product Offered

Table 134. DHN Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. DHN Main Business

Table 136. DHN Latest Developments

Table 137. WINSUN Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 138. WINSUN Veterinary Biologics Product Offered

Table 139. WINSUN Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. WINSUN Main Business

Table 141. WINSUN Latest Developments

Table 142. Elanco/Eli Lilly Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 143. Elanco/Eli Lilly Veterinary Biologics Product Offered

Table 144. Elanco/Eli Lilly Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. Elanco/Eli Lilly Main Business

Table 146. Elanco/Eli Lilly Latest Developments

Table 147. Virbac Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 148. Virbac Veterinary Biologics Product Offered

Table 149. Virbac Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. Virbac Main Business

Table 151. Virbac Latest Developments

Table 152. Jinyu Bio-Technology Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 153. Jinyu Bio-Technology Veterinary Biologics Product Offered

Table 154. Jinyu Bio-Technology Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. Jinyu Bio-Technology Main Business

Table 156. Jinyu Bio-Technology Latest Developments

Table 157. ChengDu Tecbond Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 158. ChengDu Tecbond Veterinary Biologics Product Offered

Table 159. ChengDu Tecbond Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 160. ChengDu Tecbond Main Business

Table 161. ChengDu Tecbond Latest Developments

Table 162. CAVAC Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 163. CAVAC Veterinary Biologics Product Offered

Table 164. CAVAC Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 165. CAVAC Main Business

Table 166. CAVAC Latest Developments

Table 167. Kyoto Biken Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 168. Kyoto Biken Veterinary Biologics Product Offered

Table 169. Kyoto Biken Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 170. Kyoto Biken Main Business

Table 171. Kyoto Biken Latest Developments

Table 172. FATRO Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 173. FATRO Veterinary Biologics Product Offered

Table 174. FATRO Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 175. FATRO Main Business

Table 176. FATRO Latest Developments

Table 177. Vaksindo Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 178. Vaksindo Veterinary Biologics Product Offered

Table 179. Vaksindo Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 180. Vaksindo Main Business

Table 181. Vaksindo Latest Developments

Table 182. Bio-Labs Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 183. Bio-Labs Veterinary Biologics Product Offered

Table 184. Bio-Labs Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 185. Bio-Labs Main Business

Table 186. Bio-Labs Latest Developments

Table 187. Avimex Animal Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 188. Avimex Animal Veterinary Biologics Product Offered

Table 189. Avimex Animal Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 190. Avimex Animal Main Business

Table 191. Avimex Animal Latest Developments

List of Figures

Figure 1. Picture of Veterinary Biologics

Figure 2. Veterinary Biologics Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Veterinary Biologics Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Veterinary Biologics Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Veterinary Biologics Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Vaccines

Figure 10. Product Picture of Monoclonal Antibodies

Figure 11. Global Veterinary Biologics Sales Market Share by Type in 2021

Figure 12. Global Veterinary Biologics Revenue Market Share by Type (2017-2022)

Figure 13. Veterinary Biologics Consumed in Llivestock

Figure 14. Global Veterinary Biologics Market: Llivestock (2017-2022) & (K Units)

Figure 15. Veterinary Biologics Consumed in Equine

Figure 16. Global Veterinary Biologics Market: Equine (2017-2022) & (K Units)

Figure 17. Veterinary Biologics Consumed in Other

Figure 18. Global Veterinary Biologics Market: Other (2017-2022) & (K Units)

Figure 19. Global Veterinary Biologics Sales Market Share by Application (2017-2022)

Figure 20. Global Veterinary Biologics Revenue Market Share by Application in 2021

Figure 21. Veterinary Biologics Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Veterinary Biologics Revenue Market Share by Company in 2021

Figure 23. Global Veterinary Biologics Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Veterinary Biologics Revenue Market Share by Geographic Region in 2021

Figure 25. Global Veterinary Biologics Sales Market Share by Region (2017-2022)

Figure 26. Global Veterinary Biologics Revenue Market Share by Country/Region in 2021

Figure 27. Americas Veterinary Biologics Sales 2017-2022 (K Units)

Figure 28. Americas Veterinary Biologics Revenue 2017-2022 ($ Millions)

Figure 29. APAC Veterinary Biologics Sales 2017-2022 (K Units)

Figure 30. APAC Veterinary Biologics Revenue 2017-2022 ($ Millions)

Figure 31. Europe Veterinary Biologics Sales 2017-2022 (K Units)

Figure 32. Europe Veterinary Biologics Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Veterinary Biologics Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Veterinary Biologics Revenue 2017-2022 ($ Millions)

Figure 35. Americas Veterinary Biologics Sales Market Share by Country in 2021

Figure 36. Americas Veterinary Biologics Revenue Market Share by Country in 2021

Figure 37. United States Veterinary Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Veterinary Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Veterinary Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Veterinary Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Veterinary Biologics Sales Market Share by Region in 2021

Figure 42. APAC Veterinary Biologics Revenue Market Share by Regions in 2021

Figure 43. China Veterinary Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Veterinary Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Veterinary Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Veterinary Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Veterinary Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Veterinary Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Veterinary Biologics Sales Market Share by Country in 2021

Figure 50. Europe Veterinary Biologics Revenue Market Share by Country in 2021

Figure 51. Germany Veterinary Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Veterinary Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Veterinary Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Veterinary Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Veterinary Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Veterinary Biologics Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Veterinary Biologics Revenue Market Share by Country in 2021

Figure 58. Egypt Veterinary Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Veterinary Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Veterinary Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Veterinary Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Veterinary Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Veterinary Biologics in 2021

Figure 64. Manufacturing Process Analysis of Veterinary Biologics

Figure 65. Industry Chain Structure of Veterinary Biologics

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390